XYZ CBD represents the gold standard in the CBD industry. Under the supervision of world-class experts in science, chemistry and organic processing, the CBD isolate we produce will bring transformative health, wellness and healing therapies to those for whom traditional alternatives have failed. While meeting critical market demand, our agricultural and manufacturing operations will provide life-changing economic opportunity for our employees, affiliates, vendors and partners.
Research, Vision, and Opportunity
XYZ CBD Group, Inc., is a Kentucky-based company dedicated to transforming lives through the cultivation and production of cannabidiol, or CBD, an organic component proven to have far-reaching physiological benefits for both humans and animals. XYZ CBD will be a leading supplier of CBD in a $22 billion market space that is acutely underserved.
Safe, Scientific and State-of-the-Art
Purified CBD does not contain any psychoactive THC. The bi-partisan Hemp Farming Act of 2018 is federal legislation that aims to legalize hemp as an agricultural commodity and remove it from the list of controlled substances. Using some of the industry’s most stringent processes and procedures, our facility will adhere to quality control standards comparable to those in the pharmaceutical industry. The ongoing research demonstrating CBD Isolate’s numerous health benefits (therapeutic, antioxidant and neuroprotective properties, to name a few), has sent demand soaring. Current production capacity is inadequate. Our singular focus is to work with the world’s leading producers of consumer pharmaceuticals, cosmeceuticals, nutraceuticals, wellness, beauty and pet products and become the No. 1 U.S.-based supplier, with a peerless reputation for quality, integrity and safety.
The Future of Sustainable Living
Increasingly, today’s consumers – and the consumers of the future – are interested in sustainable and “green” personal lifestyle products. An upscale and well-educated demographic, these consumers represent more than 25 percent of U.S. shoppers, generating more than $290 billion in sales each year. Specialty products in this category earn brand loyalty based on values rather than price. The channel includes cosmeceutical, nutraceutical and supplement products for health, wellness and body care. Naturally, CBD is in high demand for its proven ability to deliver a unique variety of healthful benefits organically.
A wide range of physiological conditions have been proven to be treatable with CBD therapies, resulting in many cases in suppressed or diminished symptoms, both temporary and long-term. Documented results range from the restoration of motor capacity to experiencing a renewed sense of focus and serenity. Nausea, seizures, psychoses, neurodegenerative disorders, tumor and cancer cells, anxiety, depression, chronic pain and inflammation are areas of opportunity for the benefits of CBD. XYZ will develop partnerships with major pharmaceutical manufacturers to meet the growing market demand.
Groundbreaking Pet Care
Research verifies that pets experience the benefits of CBD in many of the same ways as their human counterparts. Pet owners are willing to invest in premium products that contribute to the health, happiness and longevity of their furry companions, presenting a robust market opportunity for XYZ CBD and its commercial partners. Experts estimate that from 2012 to 2016, the pet food supplement market averaged yearly growth of nearly 4 percent, with sales reaching $580 million in 2016. Just as our pets improve our quality of life, CBD represents a safe and effective way to improve theirs.
Because of the many known and potential benefits CBD provides, companies are seeking opportunities to infuse it into a wide range of products, including prescription and over-the-counter therapies for psychological and neurological disorders, cellular health and regeneration, wellness and body care, depression, pain, pet care and many other applications. The proven benefits, known in some cases to dramatically relieve chronic physical conditions, have sparked widespread demand that is expected to rise for the foreseeable future.
The process of producing CBD Isolate starts with growing hemp organically. XYZ is a participating partner in the Kentucky Department of Agriculture Industrial Hemp Research Pilot Program. Under the direction of our chief farming officer, and licensed by the Commonwealth of Kentucky, our growing operations are scheduled to get underway in 2019. Construction of a world-class, full-scale CBD extraction, processing and production facility will also begin in 2019. As production ramps up, XYZ will emerge as a preferred commercial supplier of isolated CBD, focused on serving industry-leading product developers requiring the highest benchmarks of quality control.